In an experimental model of streptozotocin-induced diabetes, an anti-inflammatory action on COX2 has been observed via the activation of the NRF2/HO-1 signalling pathway, which protects against neuron damage in diabetes [124]. Here, PTGS2 is linked to diabetes mellitus.